Pfizer Inc SEC filings PFE
Pfizer Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 26, 2021. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 20, 2025 | — |
| FWP | Free writing prospectus | Nov 19, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| FWP | Free writing prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| FWP | Free writing prospectus | May 17, 2023 | — |
| 424B3 | Prospectus | May 15, 2023 | — |
| S-8 | Employee stock plan registration | Feb 27, 2023 | — |
| 424B5 | Prospectus supplement | Aug 17, 2021 | — |
| FWP | Free writing prospectus | Aug 16, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| S-3ASR | Automatic shelf registration | Feb 26, 2021 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PFE (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 78003
- Former names
- PFIZER INC (until Nov 3, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.